Supernus Pharmaceuticals Inc. (SUPN) Declined -7.37% or -2.79 To Price $35.06 On Wednesday


Supernus Pharmaceuticals Inc. (SUPN) declined -7.37% or -2.79 to $35.06. It is about 1.24 million shares traded, which is 238.49% compare to the average total volume 517973. The market cap of SUPN is $1.83 billion. The year to date change is 8.13%. The 52 week price range is from $30.05 to $61.25. Price of SUPN have changed -1.97% during last week. It have changed -1.36% over last month, 1.15% over last 3 months, -21.65% over last 6 months and -16.45% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SUPN is 37.72. It is 7.59% above current price. The 200-day Moving Averages for SUPN is 43.25. It is 23.36% above current price. The 52-week High is 61.25. It is 74.70% from the current price. The 52-week Low is 30.05. It is -14.29% from current price.

There are some statistics of SUPN. It is has market cap $1.83 billion. The share outstanding is 52.32 million. The average volume is 517973. The percent of top 15 Institution holding is 149.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SUPN is 30.81%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SUPN is 15.83%.


Tags:

Share this post